Alvotech (NASDAQ:ALVOW) Short Interest Down 88.7% in April

Alvotech (NASDAQ:ALVOW) saw a significant decrease in short interest in April. As of April 30th, there was short interest totaling 1,032 shares, a decrease of 88.7% from the April 15th total of 9,151 shares. Based on an average trading volume of 2,140 shares, the short-interest ratio is currently 0.5 days.

Alvotech Stock Performance

Shares of ALVOW stock remained flat at $0.25 during mid-day trading on Wednesday. The company’s stock had a trading volume of 2,165 shares, compared to its average volume of 4,307. The firm’s 50-day moving average price is $0.28 and its two-hundred day moving average price is $0.55. Alvotech has a 12 month low of $0.15 and a 12 month high of $3.00.

About Alvotech

Alvotech is a biopharmaceutical company specializing in the development and manufacturing of biosimilar medicines. Headquartered in Reykjavík, Iceland, the company focuses on creating high-quality, cost-effective alternatives to branded biologic therapies. Since its founding in 2013, Alvotech has built an integrated platform that spans research and development, clinical trials, regulatory submissions and commercial manufacturing.

Alvotech’s pipeline includes multiple biosimilar candidates addressing key therapeutic areas such as immunology, oncology and ophthalmology.